RM, C., AP, P., MN, G., M, M., JW, M., TC, S., . . . E, D. (2013). The impact of AD drug treatments on event-related potentials as markers of disease conversion. Current Alzheimer research, 10(7), 732. https://doi.org/10.2174/15672050113109990148
Chicago Style (17th ed.) CitationRM, Chapman, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, Reilly LA, and DeGrush E. "The Impact of AD Drug Treatments on Event-related Potentials as Markers of Disease Conversion." Current Alzheimer Research 10, no. 7 (2013): 732. https://doi.org/10.2174/15672050113109990148.
MLA (9th ed.) CitationRM, Chapman, et al. "The Impact of AD Drug Treatments on Event-related Potentials as Markers of Disease Conversion." Current Alzheimer Research, vol. 10, no. 7, 2013, p. 732, https://doi.org/10.2174/15672050113109990148.